{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:28:00Z","timestamp":1772623680683,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Endothelial progenitor cells and circulating endothelial cells have been proposed as useful markers of severity and disease progression in certain vascular diseases, including pulmonary arterial hypertension. Our study focused on evaluating the levels of circulating endothelial progenitor cells and circulating endothelial cells in patients with congenital left-to-right shunts and pulmonary hypertension undergoing definitive repair. Endothelial progenitor cells (identified by simultaneous co-expression of CD45dim, CD34\u2009+\u2009and KDR2\u2009+\u2009surface antibodies) and circulating endothelial cells (identified by simultaneous co-expression of inherent antibodies CD45-, CD31+, CD146\u2009+\u2009and CD105+) were prospectively measured in seventy-four children (including children with Down syndrome), median age six years (2.75\u201310), with clinically significant left-to-right shunts undergoing transcatheter or surgical repair and compared to thirty healthy controls. Endothelial progenitor cells and, particularly, circulating endothelial cells were significantly higher in children with heart disease and pulmonary arterial hypertension when compared to controls. Endothelial progenitor cells showed significant correlation with pulmonary vascular resistance index when measured both systemically (<jats:italic>r<\/jats:italic>\u2009=\u20090.259; <jats:italic>p<\/jats:italic>\u2009=\u20090.026) and in the superior vena cava (<jats:italic>r<\/jats:italic>\u2009=\u20090.302; <jats:italic>p<\/jats:italic>\u2009=\u20090.009). Children with Down syndrome showed a stronger correlation between systemic cellularity and pulmonary vascular resistance index (<jats:italic>r<\/jats:italic>\u2009=\u20090.829; <jats:italic>p<\/jats:italic>\u2009=\u20090.002). Endothelial progenitor cells were reduced along their transit through the lung, whereas circulating endothelial cells did not suffer any modification across the pulmonary circulation. In children with yet to be repaired left-to-right shunts, endothelial progenitor cells and circulating endothelial cell counts are increased compared to healthy subjects.<\/jats:p>","DOI":"10.3389\/fped.2023.1200395","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:53:51Z","timestamp":1688637231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary arterial hypertension in children with congenital heart disease: a deeper look into the role of endothelial progenitor cells and circulating endothelial cells to assess disease severity"],"prefix":"10.3389","volume":"11","author":[{"given":"Juan","family":"Calder\u00f3n-Colmenero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Mass\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Gonz\u00e1lez-Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cervantes-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Garc\u00eda-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Pa\u00e9z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela I.","family":"Pereira-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zabal-Cerdeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1160\/TH03-04-0251","article-title":"Circulating endothelial cells in pulmonary hypertension","volume":"90","author":"Bull","year":"2003","journal-title":"Thromb Haemost"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.rmed.2007.12.030","article-title":"Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension","volume":"102","author":"JunHui","year":"2008","journal-title":"Respir Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","article-title":"Circulating endothelial progenitor cells in patients with eisenmenger syndrome and idiopathic pulmonary arterial hypertension","volume":"117","author":"Diller","year":"2008","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","article-title":"Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease","volume":"119","author":"Smadja","year":"2009","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00246-010-9674-0","article-title":"Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease","volume":"31","author":"Smadja","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1183\/09031936.00130809","article-title":"Distinct patterns of circulating endotelial cells in pulmonary hypertension","volume":"36","author":"Smadja","year":"2010","journal-title":"Eur Respir J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10456-010-9192-y","article-title":"Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension","volume":"14","author":"Smadja","year":"2011","journal-title":"Angiogenesis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e65114","DOI":"10.1371\/journal.pone.0065114","article-title":"Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening","volume":"8","author":"Levy","year":"2013","journal-title":"PLoS ONE"},{"key":"B9","first-page":"10743","article-title":"Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS)","volume":"2015","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1086\/675995","article-title":"Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the congenital heart disease and PediatricTask forces","volume":"4","author":"Lopes","year":"2014","journal-title":"Pulm Vasc Res Inst (PVRI) Pulmonary Circ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1253\/circj.CJ-13-1263","article-title":"Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease \u2013do we have the good tools to predict success?","volume":"78","author":"Myers","year":"2014","journal-title":"Circ J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1582-4934.2008.00639.x","article-title":"Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence","volume":"13","author":"Sabatier","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1538-7836.2008.02918.x","article-title":"Circulating endothelial cells: from bench to clinical practice","volume":"6","author":"Shantsila","year":"2008","journal-title":"J ThrombHaemost"},{"key":"B15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1160\/TH04-09-0578","article-title":"Circulating endothelial cells: biomarker of vascular disease","volume":"93","author":"Blann","year":"2005","journal-title":"Thromb Haemost"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2006.02.078","article-title":"Circulating endothelial cells in cardiovascular disease","volume":"48","author":"Boos","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2005.12.024","article-title":"Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?","volume":"188","author":"Blann","year":"2006","journal-title":"Atherosclerosis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000083851","article-title":"Circulating endothelial cells: realities and promises in vascular disorders pathophysiol","volume":"33","author":"Dignat-George","year":"","journal-title":"Thromb Haemost"},{"key":"B19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1160\/TH04-09-0578","article-title":"Circulating endothelial cells. Biomarker of vascular disease","volume":"93","author":"Blann","year":"2005","journal-title":"Thromb Haemost"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1161\/01.CIR.0000074242.66719.4A","article-title":"Endothelial progenitor cells: new hope for a broken heart","volume":"107","author":"Szmitko","year":"2003","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hlc.2014.02.007","article-title":"Endothelial progenitor cells and pulmonary arterial hypertension","author":"Chen","year":"2014","journal-title":"Heart, Lung and Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2045-8932.78095","article-title":"Progenitor cells in pulmonary vascular remodelling","volume":"1","author":"Yeager","year":"2011","journal-title":"Pulm Circ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2010.03.003","article-title":"Endothelial progenitor cells in pulmonary arterial hypertension","volume":"20","author":"Diller","year":"2010","journal-title":"Trends Cardiovasc Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/CIRCRESAHA.115.307035","article-title":"Resident PW1+ progenitor cells participate in vascular remodelling during pulmonary arterial hypertension","volume":"118","author":"Dierick","year":"2016","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1164\/rccm.201104-0664ED","article-title":"Emerging role of C-kit1 progenitor cells in pulmonary hypertension","volume":"184","author":"Schwarz","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1164\/rccm.201006-0905OC","article-title":"C-kit positive cells accumulate in remodelled vessels of idiopathic pulmonary arterial hypertension","volume":"183","author":"Montani","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1164\/rccm.201502-0407OC","article-title":"Bone marrow\u2013derived cells contribute to the pathogenesis o pulmonary arterial hypertension","volume":"193","author":"Yan","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","article-title":"Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with down syndrome","volume":"169","author":"Weijerman","year":"2010","journal-title":"Eur J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/GIM.0b013e3181634867","article-title":"Ethnicity, sex, and the incidence of congenital heart defects: a report from the national down syndrome project","volume":"10","author":"Freeman","year":"2008","journal-title":"Genet Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1542\/peds.58.6.893","article-title":"The clinical course of cardiac disease in down's syndrome","volume":"58","author":"Greenwood","year":"1976","journal-title":"Pediatrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1755-8794-3-40","article-title":"Impairment of circulating endothelial progenitors in down syndrome","volume":"3","author":"Costa","year":"2010","journal-title":"BMC Med Genomics"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1200395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:53:55Z","timestamp":1688637235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1200395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":32,"alternative-id":["10.3389\/fped.2023.1200395"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1200395","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"article-number":"1200395"}}